Evolving Concepts of Type 2 Diabetes Management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34688420.
- Also identified by DOI 10.1016/j.mcna.2021.06.003 and PMC identifier 13012870.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With the concept of patient-centered care in mind, this article outlines the current diabetes medications available for glucose lowering and the characteristics of each of these medications that need to be considered in shared decision-making for durable and effective therapy. Important patient characteristics such as weight, risk for hypoglycemia, cost, social determinants of health, and medical literacy need to be considered. The evidence-base informing the use of antihyperglycemic agents has changed dramatically due to 2008 FDA guidance for cardiovascular safety and cardiorenal protection with antihyperglycemic agents. New evidence supports an approach to diabetes management that addresses pre-existing cardiorenal disease.
Medical subject headings
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents